|
Parent-Based Treatment for Adolescent Anxiety
RECRUITINGN/ASponsored by Yale University
Actively Recruiting
PhaseN/A
SponsorYale University
Started2025-11-01
Est. completion2028-11
Eligibility
Age14 Years – 17 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07219992
Summary
This study aims to test the efficacy of a parent-only approach to treating anxiety disorders in adolescents: SPACE (Supportive Parenting for Anxious Childhood Emotions). The comparator is another parent-based approach, PES (Parent Education and Support). The study design is a randomized controlled trial with 2 treatment arms and 3 assessment points (pre, post, and follow-up) using questionnaire data and clinical interviews.
Eligibility
Age: 14 Years – 17 YearsHealthy volunteers accepted
Inclusion Criteria: * Meet criteria for a primary DSM-5 AD, including separation anxiety disorder, social anxiety disorder, generalized anxiety disorder, specific phobia, panic disorder, and agoraphobia (determined by the ADIS-C/P). * Cease all other psychosocial treatment, upon consultation with the project staff and service provider. * Not currently use any psychotropic medication, other than a stable dose (i.e., same dose for a minimum of 6 months prior to enrollment; no changes during course of the study) of a stimulant medication or selective serotonin reuptake inhibitor (SSRI). * Have an eligible and willing participating parent (see parent exclusions below). Exclusion Criteria: Adolescent: * Meet criteria for any DSM-5 disorder more impairing than the most impairing AD (determined by the ADIS-C/P). * Have any of the following disorders: autism spectrum disorder; intellectual disability; neurocognitive disorders; bipolar disorder; schizophrenia and other psychotic disorders; and alcohol and substance use disorders (determined by the Health History Form and ADIS-C/P). * Report a suicide attempt in the last 3 months, or current suicide intent and plans (determined by the ASQ). * Be a victim of past or present undisclosed abuse requiring investigation or ongoing supervision by the Department of Social Services. * Not have sufficient proficiency with the English language to complete assessments. Parents: * Have any of the following: intellectual disability; neurocognitive disorders; untreated bipolar disorder; untreated schizophrenia and other psychotic disorders; and untreated alcohol and substance use disorders (determined by the Health History Form). * Not be living with the adolescent at least 50% of the time for at least one year prior to enrollment. * Not have sufficient proficiency with the English language to complete assessments and treatment.
Conditions2
AnxietyAnxiety Disorder of Adolescence
Locations1 site
Yale Child Study Center
New Haven, Connecticut, 06519
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorYale University
Started2025-11-01
Est. completion2028-11
Eligibility
Age14 Years – 17 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07219992